Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Lucid Diagnostics Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
AI
Alyeska Investment Group, L.P.
|
8.9M | 4.36% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding8.9M (Q2'26)
Change over 8 quarters+8.9M
Share of the company4.360%
|
||||||
|
B
BlackRock, Inc.
|
8.4M | 4.12% | +3.7M (+80.5%) | 2021 | 0.0% | |
|
Shares held by quarter
Peak holding8.4M (Q2'26)
Change over 8 quarters+8.3M
Share of the company4.120%
|
||||||
28 more super investors behind a free account
See every manager holding Lucid Diagnostics Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$4.87M | 4.5M | 2.24% | 0.00% | June 30, 2026 |
|
AH
abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund
|
$4.09M | 3.8M | 1.88% | 0.50% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Lucid Diagnostics Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
P
PAVmed Inc.
5%+ holder
13D · 27.5%
|
38.8M | 19.10% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
AL
Aklog Lishan
Insider
|
3.6M | 1.79% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company1.790%
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of Lucid Diagnostics Inc.
Sign up freeLoading...